BDF Gestion Reduces Stock Position in Intuitive Surgical, Inc. $ISRG

BDF Gestion decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,963 shares of the medical equipment provider’s stock after selling 1,131 shares during the quarter. Intuitive Surgical comprises about 1.2% of BDF Gestion’s holdings, making the stock its 11th largest position. BDF Gestion’s holdings in Intuitive Surgical were worth $9,607,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Holos Integrated Wealth LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth about $25,000. Kilter Group LLC acquired a new position in shares of Intuitive Surgical in the second quarter valued at approximately $27,000. Greykasell Wealth Strategies Inc. purchased a new position in shares of Intuitive Surgical during the third quarter valued at approximately $27,000. Caitlin John LLC acquired a new stake in Intuitive Surgical during the third quarter worth approximately $30,000. Finally, Riggs Asset Managment Co. Inc. boosted its position in Intuitive Surgical by 84.2% during the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after acquiring an additional 32 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have weighed in on ISRG. Truist Financial boosted their price target on Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a report on Thursday, December 18th. TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Wells Fargo & Company upped their target price on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Citigroup upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price on the stock in a research report on Wednesday, March 11th. Finally, Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 19th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $614.95.

Intuitive Surgical Stock Up 0.0%

Shares of ISRG opened at $478.04 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The company’s fifty day moving average is $500.94 and its two-hundred day moving average is $513.62. The firm has a market cap of $169.77 billion, a PE ratio of 60.59, a price-to-earnings-growth ratio of 3.69 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same period in the prior year, the firm posted $2.21 EPS. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other news, SVP Patricia L. Wadors sold 220 shares of Intuitive Surgical stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Mark Brosius sold 645 shares of the business’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the sale, the senior vice president owned 1,613 shares of the company’s stock, valued at $782,321.13. The trade was a 28.57% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 32,943 shares of company stock valued at $17,279,568. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.